HELLUMS RHONDA LYNETTE 4
4 · Silence Therapeutics plc · Filed Jan 6, 2026
Insider Transaction Report
Form 4
HELLUMS RHONDA LYNETTE
DirectorChief Financial Officer
Transactions
- Award
Employee Share Option (Right to Buy)
2026-01-02+375,000→ 375,000 totalExercise: $2.05Exp: 2036-01-02→ Ordinary Shares (375,000 underlying)
Footnotes (1)
- [F1]One fourth (1/4th) of the shares subject to the option shall vest on January 2, 2027 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer on each such vesting date.